News Listing

News Listing

Garvan welcomes Professor Mark Febbraio as Head of Diabetes and Metabolism

Garvan welcomes Professor Mark Febbraio as Head of Diabetes and Metabolism

Apr 08, 2015 12:00 AM
Garvan is very pleased to announce that Professor Mark Febbraio has joined us as Head of the Diabetes and Metabolism Division

More…

Professors Mattick and Eisman inducted into Australian Academy of Health and Medical Sciences

Professors Mattick and Eisman inducted into Australian Academy of Health and Medical Sciences

Apr 07, 2015 04:00 AM
Executive Director of Garvan, Professor John Mattick AO FAA FRCPA, and Endocrinologist Professor John Eisman AO, were recently inducted as Fellows of the newly-created Academy of Health and Medical Sciences.

More…

Memory immune cells that screen intruders as they enter lymph nodes

Memory immune cells that screen intruders as they enter lymph nodes

MEDIA RELEASE: Apr 01, 2015 03:00 AM
Garvan scientists have discovered a new population of ‘memory’ immune cells, throwing light on what the body does when it sees a microbe for the second time. This insight, and others like it, will enable the development of more targeted and effective vaccines.

More…

How bones reflect genetic variation among populations

How bones reflect genetic variation among populations

MEDIA RELEASE: Mar 30, 2015 01:00 AM
Genes that help build strong bones in Europeans or Australians may have a very different effect in people from Southeast Asia.

More…

The switch that might tame the most aggressive of breast cancers

The switch that might tame the most aggressive of breast cancers

MEDIA RELEASE: Mar 27, 2015 09:00 PM
Garvan researchers have found that so-called ‘triple-negative breast cancers’ are two distinct diseases that likely originate from different cell types. They have also found a gene that drives the aggressive disease, and hope to find a way to ‘switch it off’.

More…

The Michael J. Fox Foundation supports promising Parkinson’s project

The Michael J. Fox Foundation supports promising Parkinson’s project

MEDIA RELEASE: Mar 23, 2015 12:05 AM
Garvan scientists receive support from The Michael J. Fox Foundation for Parkinson’s Research to speed progress in developing a novel therapy for Parkinson’s disease.

More…

New gene sequencing technology like a high-powered microscope

New gene sequencing technology like a high-powered microscope

MEDIA RELEASE: Mar 10, 2015 03:00 AM
A new gene sequencing technology known as ‘Capture Sequencing’ (CaptureSeq) allows us to explore the human genome at a much higher resolution than ever before, with revolutionary implications for research and cancer diagnosis.

More…

How the landscape of the pancreatic cancer genome is coming into view

How the landscape of the pancreatic cancer genome is coming into view

MEDIA RELEASE: Feb 26, 2015 05:00 AM
Scientists from Australia and the UK have done the most in-depth analysis yet of 100 pancreatic cancer genomes and highlighted 4 subtypes that may help guide future patient treatment. The study is published in Nature today.

More…

Students Receive Awards at 2015 Lorne Genome Conference

Students Receive Awards at 2015 Lorne Genome Conference

Feb 25, 2015 02:41 PM
Congratulations to Ksenia Skvortsova, Amanda Khoury and Qian Du.

More…

Saul Bert Awarded 2014 Garvan Thesis Prize

Saul Bert Awarded 2014 Garvan Thesis Prize

Feb 19, 2015 12:00 AM
Congratulations to PhD student Saul Bert.

More…

Students Receive 2015 UNSW Research Excellence Award

Students Receive 2015 UNSW Research Excellence Award

Feb 19, 2015 12:00 AM
Congratulations to Garvan PhD candidates Deborah Burnett and Bethany Pillay.

More…

Mun Hui a Sydney Catalyst 2015 'Top-Up Research Scholar'

Mun Hui a Sydney Catalyst 2015 'Top-Up Research Scholar'

Feb 18, 2015 12:00 AM
Congratulations to Garvan Cancer PhD student Mun Ngah Hui.

More…

Associate Professor Stuart Tangye awarded a Fulbright scholarship

Associate Professor Stuart Tangye awarded a Fulbright scholarship

MEDIA RELEASE: Feb 16, 2015 05:00 AM
Associate Professor Stuart Tangye has been awarded a prestigious scholarship by the Australian American Fulbright Commission, an educational and cultural exchange program underwritten by the Australian and U.S. Governments.

More…

No more money and time down the drain say antibody experts in Nature

No more money and time down the drain say antibody experts in Nature

MEDIA RELEASE: Feb 05, 2015 05:00 AM
In today’s issue of Nature, a worldwide group of antibody experts appeal for a standardised approach to the creation and use of antibodies in research and therapeutics.

More…

Epigenetic signatures that differentiate triple-negative breast cancers

Epigenetic signatures that differentiate triple-negative breast cancers

MEDIA RELEASE: Feb 02, 2015 09:00 PM
Australian researchers have identified epigenetic ‘signatures’ that could help clinicians tell the difference between highly aggressive and more benign forms of triple-negative breast cancer.

More…

Garvan welcomes Professor Chris Goodnow as Deputy Director

Garvan welcomes Professor Chris Goodnow as Deputy Director

MEDIA RELEASE: Feb 01, 2015 09:00 AM
The Garvan Institute of Medical Research is delighted to announce that distinguished immunologist and molecular geneticist, Professor Chris Goodnow FAA FRS, has now taken up his position as the Institute’s Deputy Director. He has also assumed The Bill and Patricia Ritchie Foundation Chair.

More…

Powerful tool promises to change the way scientists view proteins

Powerful tool promises to change the way scientists view proteins

MEDIA RELEASE: Jan 30, 2015 06:00 AM
Life scientists now have access to a publicly available web resource that streamlines and simplifies the process of gleaning insight from 3D protein structures. Aquaria, as it's known, is fast, easy-to-use and contains twice as many models as all other similar resources combined.

More…

Professor Jonathan Sprent to receive AAI Lifetime Achievement Award

Professor Jonathan Sprent to receive AAI Lifetime Achievement Award

MEDIA RELEASE: Jan 22, 2015 10:00 AM
The American Association of Immunologists (AAI) has selected Professor Jonathan Sprent FAA FRS, from Sydney’s Garvan Institute of Medical Research, to be the 2015 recipient of the AAI Lifetime Achievement Award.

More…

Start up company to commercialise antibody-stabilisation technology

Start up company to commercialise antibody-stabilisation technology

MEDIA RELEASE: Jan 15, 2015 11:00 AM
The Garvan Institute of Medical Research announces the launch of spin-off company Solvanix Pty Ltd, set up to commercialise a novel technology that will improve the stability of therapeutic monoclonal antibodies. Solvanix has secured a $2 million commitment from Australia’s Medical Research Commercialisation Fund (MRCF), and will be based at Garvan.

More…